Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range: CHF154,700.00 - CHF287,300.00 Job Description Summary #LI-Hybrid Job Description Key responsibilities Drive disease area strategy execution and performance management across the region, ensuring country plans are aligned with regional and international priorities. Provide disease